Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review.

about

Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review.

Item

http://www.wikidata.org/entity/Q50350183

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Successful treatment of metast ...... o cases and literature review.

@en

Successful treatment of metast ...... o cases and literature review.

@nl

type

Item

label

Successful treatment of metast ...... o cases and literature review.

@en

Successful treatment of metast ...... o cases and literature review.

@nl

prefLabel

Successful treatment of metast ...... o cases and literature review.

@en

Successful treatment of metast ...... o cases and literature review.

@nl

P1476

Successful treatment of metast ...... o cases and literature review.

@en

P2093

Hairong Zhou

http://www.w3.org/2001/XMLSchema#string

Haoran Zhang

http://www.w3.org/2001/XMLSchema#string

Jingru Yang

http://www.w3.org/2001/XMLSchema#string

Minghong Bi

http://www.w3.org/2001/XMLSchema#string

Mohan Shi

http://www.w3.org/2001/XMLSchema#string

Yaping Wang

http://www.w3.org/2001/XMLSchema#string

Zhenyuan Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.

Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy.

Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.

P304

883-890

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S148412

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29497319

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5823067

http://www.w3.org/2001/XMLSchema#string